GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a truly shift in how we approach high blood sugar. These new drugs function to mimicking the body’s own GLP-1 process, which https://elodieceuc657639.blogdomago.com/40413681/glp-1-a-revolutionary-advance-in-diabetes-management